In “To Your Health,” the Washington Post (2/7, McGinley) reports that research published online in the Journal of the American Medical Association suggests physicians “often fail to recommend genetic testing for breast-cancer patients, even those who are at high risk for mutations linked to ovarian and other cancers.” The research “also found that many women who would benefit from genetic counseling do not receive it.”
Aunt Minnie (2/6, Yee) reports that research suggests “using digital breast tomosynthesis (DBT) in combination with full-field digital mammography (FFDM) among Medicaid enrollees could save state programs more than $200,000 per year – and individual plans more than $12,000 annually.” The “cost savings would come from fewer recalls and earlier cancer detection, which benefit the women themselves, the authors wrote.” The findings were published online in the Journal of the American College of Radiology.
Aunt Minnie (2/3) reports that the ACR has issued “an updated version of its 2016 Digital Mammography Quality Control manual.”
Medscape (2/1, Mulcahy) reports that researchers found that “there was a ‘substantial,’ statistically significant reduction in breast cancer mortality between 1991 and 2005 associated with the” UK National Health Service Breast Screening Programme. Investigators found that an “invitation to be screened, when compared with not being invited, was” linked to “a reduction in breast cancer mortality in 1991 to 2005 of 21%...after adjustment for three major variables (age, socioeconomic status, and lead-time).” Medscape points out that the program “is one of the largest in the world and has invited women aged 50 to 64 years to be screened every 3 years.” The findings were published in the British Journal of Cancer.
Aunt Minnie (2/1, Yee) reports that while research has indicated “women with dense breast tissue have a twofold increased risk of developing primary breast cancer,” research published online in Cancer suggests “women with dense tissue also have an increased risk of developing cancer in the other breast.” This “finding could affect the management of women with dense tissue who have been diagnosed with primary breast cancer, wrote” the investigators.